RISIVRIX Trademark

Trademark Overview


On Thursday, May 16, 2002, a trademark application was filed for RISIVRIX with the United States Patent and Trademark Office. The USPTO has given the RISIVRIX trademark a serial number of 78129162. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, September 28, 2012. This trademark is owned by SmithKline Beecham Biologicals S.A.. The RISIVRIX trademark is filed in the Pharmaceutical Products category with the following description:

vaccines for human use

General Information


Serial Number78129162
Word MarkRISIVRIX
Filing DateThursday, May 16, 2002
Status710 - CANCELLED - SECTION 8
Status DateFriday, September 28, 2012
Registration Number3017157
Registration DateTuesday, November 22, 2005
Mark Drawing1000 - Typeset: Word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, August 30, 2005

Trademark Statements


Certificate of Correction for RegistrationIn the statement, Column 2, line 1 through 4 " priority claimed under sec. 44 ( d) on united kingdom application no. 22999908,filed 5-7-2002, re no. 00293134, dated 7-29-2004, expires 11-6-2012" should be deleted, and PRIORITY CLAIMED UNDER SEC. 44 ( D ) ON UNITED KINGDOM APPLICATION NO. 2299908, FILED 5-7-2012, REG. NO 2299908, DATED 5-7-2002, EXPIRES 5-7-2012 OWNER OF ERPN COMNTY TM OFC REG. NO. 002923134 DATED 7-29-2004, EXPIRES 11-6-2012 IS INSERTED
Goods and Servicesvaccines for human use

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, September 28, 2012
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameGLAXOSMITHKLINE BIOLOGICALS S.A.
Party Type31 - New Owner After Registration
Legal Entity Type03 - Corporation
AddressB-1330 RIXENSART
BE

Party NameSmithKline Beecham Biologicals S.A.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressRixensart B-1330
BE

Party NameSmithKline Beecham Biologicals S.A.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressRixensart B-1330
BE

Party NameSmithKline Beecham Biologicals S.A.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressRixensart B-1330
BE

Trademark Events


Event DateEvent Description
Friday, March 15, 2013TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, September 28, 2012CANCELLED SEC. 8 (6-YR)
Thursday, May 13, 2010TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, December 3, 2009ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, December 3, 2009TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, January 23, 2008CORRECTION UNDER SECTION 7 ¿ PROCESSED
Friday, July 13, 2007ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
Friday, July 6, 2007CORRECTION UNDER SECTION 7 ¿ PROCESSED
Friday, April 13, 2007ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
Thursday, April 12, 2007CORRECTION UNDER SECTION 7 ¿ PROCESSED
Friday, March 23, 2007ASSIGNED TO PARALEGAL
Thursday, March 8, 2007SEC 7 REQUEST FILED
Thursday, March 8, 2007PAPER RECEIVED
Tuesday, November 22, 2005REGISTERED-PRINCIPAL REGISTER
Tuesday, August 30, 2005PUBLISHED FOR OPPOSITION
Wednesday, August 10, 2005NOTICE OF PUBLICATION
Thursday, May 12, 2005LAW OFFICE PUBLICATION REVIEW COMPLETED
Monday, May 9, 2005ASSIGNED TO LIE
Friday, April 29, 2005APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, November 17, 2004AMENDMENT FROM APPLICANT ENTERED
Tuesday, November 9, 2004CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, November 9, 2004TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, May 13, 2004INQUIRY TO SUSPENSION E-MAILED
Monday, March 22, 2004CASE FILE IN TICRS
Thursday, September 12, 2002LETTER OF SUSPENSION MAILED

Related Keywords


risivrix human vaccines